Video

Aasma Shaukat, MD, MPH: How AI Can Help With Cancer Screenings

Author(s):

Artificial intelligence is being used to help detect polyps for patients undergoing a colonoscopy.

There are a number of utilities for artificial intelligence (AI) in medicine that could have a drastic impact on the field?

One such method is for polyp detection following a colonoscopy for colorectal cancer screenings.

In a presentation during the 2023 Digestive Disease Week (DDW) in Chicago, Aasma Shaukat, MD, MPH, Director of Research Outcomes, Division of Gastroenterology and Hepatology, NYU Langone, discussed how doctors can better use new technologies like AI for cancer screenings.

“Artificial intelligence is here to stay,” Shaukat said in an interview with HCPLive®. “It will make our job in delivering health care and promoting and improving health easier.”

Shaukat said the main benefit of AI are in polyp detection and harnessing the ability to create better risk prediction models.

Another use in the future that may become important is utilizing new technologies in an effort to develop non-invasive screening techniques to replace or give options other than a colonoscopy.

“AI can also expand our options for non-invasive screening,” Shaukat said. “There are several tests being developed that pick up certain signatures or signals in the blood and then they use AI to refine the model that improves the risk prediction of that cancer test.”

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.